IBDEI0OZ ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25152,2)
 ;;=^5003402
 ;;^UTILITY(U,$J,358.3,25153,0)
 ;;=F18.980^^95^1182^3
 ;;^UTILITY(U,$J,358.3,25153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25153,1,3,0)
 ;;=3^Inhalant Induced Anxiety Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25153,1,4,0)
 ;;=4^F18.980
 ;;^UTILITY(U,$J,358.3,25153,2)
 ;;=^5003414
 ;;^UTILITY(U,$J,358.3,25154,0)
 ;;=F18.94^^95^1182^6
 ;;^UTILITY(U,$J,358.3,25154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25154,1,3,0)
 ;;=3^Inhalant Induced Depressive Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25154,1,4,0)
 ;;=4^F18.94
 ;;^UTILITY(U,$J,358.3,25154,2)
 ;;=^5003409
 ;;^UTILITY(U,$J,358.3,25155,0)
 ;;=F18.17^^95^1182^7
 ;;^UTILITY(U,$J,358.3,25155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25155,1,3,0)
 ;;=3^Inhalant Induced Major Neurocog Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25155,1,4,0)
 ;;=4^F18.17
 ;;^UTILITY(U,$J,358.3,25155,2)
 ;;=^5003388
 ;;^UTILITY(U,$J,358.3,25156,0)
 ;;=F18.27^^95^1182^8
 ;;^UTILITY(U,$J,358.3,25156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25156,1,3,0)
 ;;=3^Inhalant Induced Major Neurocog Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25156,1,4,0)
 ;;=4^F18.27
 ;;^UTILITY(U,$J,358.3,25156,2)
 ;;=^5003401
 ;;^UTILITY(U,$J,358.3,25157,0)
 ;;=F18.97^^95^1182^9
 ;;^UTILITY(U,$J,358.3,25157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25157,1,3,0)
 ;;=3^Inhalant Induced Major Neurocog Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25157,1,4,0)
 ;;=4^F18.97
 ;;^UTILITY(U,$J,358.3,25157,2)
 ;;=^5003413
 ;;^UTILITY(U,$J,358.3,25158,0)
 ;;=F18.188^^95^1182^10
 ;;^UTILITY(U,$J,358.3,25158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25158,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25158,1,4,0)
 ;;=4^F18.188
 ;;^UTILITY(U,$J,358.3,25158,2)
 ;;=^5003390
 ;;^UTILITY(U,$J,358.3,25159,0)
 ;;=F18.288^^95^1182^11
 ;;^UTILITY(U,$J,358.3,25159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25159,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25159,1,4,0)
 ;;=4^F18.288
 ;;^UTILITY(U,$J,358.3,25159,2)
 ;;=^5003403
 ;;^UTILITY(U,$J,358.3,25160,0)
 ;;=F18.988^^95^1182^12
 ;;^UTILITY(U,$J,358.3,25160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25160,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25160,1,4,0)
 ;;=4^F18.988
 ;;^UTILITY(U,$J,358.3,25160,2)
 ;;=^5003415
 ;;^UTILITY(U,$J,358.3,25161,0)
 ;;=F18.159^^95^1182^13
 ;;^UTILITY(U,$J,358.3,25161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25161,1,3,0)
 ;;=3^Inhalant Induced Psychotic Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25161,1,4,0)
 ;;=4^F18.159
 ;;^UTILITY(U,$J,358.3,25161,2)
 ;;=^5003387
 ;;^UTILITY(U,$J,358.3,25162,0)
 ;;=F18.259^^95^1182^14
 ;;^UTILITY(U,$J,358.3,25162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25162,1,3,0)
 ;;=3^Inhalant Induced Psychotic Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25162,1,4,0)
 ;;=4^F18.259
 ;;^UTILITY(U,$J,358.3,25162,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,25163,0)
 ;;=F18.959^^95^1182^15
 ;;^UTILITY(U,$J,358.3,25163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25163,1,3,0)
 ;;=3^Inhalant Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25163,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,25163,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,25164,0)
 ;;=F18.99^^95^1182^22
 ;;^UTILITY(U,$J,358.3,25164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25164,1,3,0)
 ;;=3^Inhalant Related Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,25164,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,25164,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,25165,0)
 ;;=F18.20^^95^1182^25
 ;;^UTILITY(U,$J,358.3,25165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25165,1,3,0)
 ;;=3^Inhalant Use Disorder,Severe
 ;;^UTILITY(U,$J,358.3,25165,1,4,0)
 ;;=4^F18.20
 ;;^UTILITY(U,$J,358.3,25165,2)
 ;;=^5003392
 ;;^UTILITY(U,$J,358.3,25166,0)
 ;;=Z00.6^^95^1183^1
 ;;^UTILITY(U,$J,358.3,25166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25166,1,3,0)
 ;;=3^Exam of Participant of Control in Clinical Research Program
 ;;^UTILITY(U,$J,358.3,25166,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,25166,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,25167,0)
 ;;=F45.22^^95^1184^1
 ;;^UTILITY(U,$J,358.3,25167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25167,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,25167,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,25167,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,25168,0)
 ;;=F45.8^^95^1184^16
 ;;^UTILITY(U,$J,358.3,25168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25168,1,3,0)
 ;;=3^Somatoform Disorders,Other Specified
 ;;^UTILITY(U,$J,358.3,25168,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,25168,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,25169,0)
 ;;=F45.0^^95^1184^14
 ;;^UTILITY(U,$J,358.3,25169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25169,1,3,0)
 ;;=3^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,25169,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,25169,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,25170,0)
 ;;=F45.9^^95^1184^15
 ;;^UTILITY(U,$J,358.3,25170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25170,1,3,0)
 ;;=3^Somatoform Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,25170,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,25170,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,25171,0)
 ;;=F45.1^^95^1184^13
 ;;^UTILITY(U,$J,358.3,25171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25171,1,3,0)
 ;;=3^Somatic Symptom Disorder
 ;;^UTILITY(U,$J,358.3,25171,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,25171,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,25172,0)
 ;;=F44.4^^95^1184^2
 ;;^UTILITY(U,$J,358.3,25172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25172,1,3,0)
 ;;=3^Conversion Disorder w/ Abnormal Movement
 ;;^UTILITY(U,$J,358.3,25172,1,4,0)
 ;;=4^F44.4
 ;;^UTILITY(U,$J,358.3,25172,2)
 ;;=^5003579
 ;;^UTILITY(U,$J,358.3,25173,0)
 ;;=F44.6^^95^1184^3
 ;;^UTILITY(U,$J,358.3,25173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25173,1,3,0)
 ;;=3^Conversion Disorder w/ Anesthesia or Sensory Loss
 ;;^UTILITY(U,$J,358.3,25173,1,4,0)
 ;;=4^F44.6
 ;;^UTILITY(U,$J,358.3,25173,2)
 ;;=^5003581
 ;;^UTILITY(U,$J,358.3,25174,0)
 ;;=F44.5^^95^1184^4
 ;;^UTILITY(U,$J,358.3,25174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25174,1,3,0)
 ;;=3^Conversion Disorder w/ Attacks or Seizures
 ;;^UTILITY(U,$J,358.3,25174,1,4,0)
 ;;=4^F44.5
 ;;^UTILITY(U,$J,358.3,25174,2)
 ;;=^5003580
 ;;^UTILITY(U,$J,358.3,25175,0)
 ;;=F44.7^^95^1184^5
 ;;^UTILITY(U,$J,358.3,25175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25175,1,3,0)
 ;;=3^Conversion Disorder w/ Mixed Symptoms
 ;;^UTILITY(U,$J,358.3,25175,1,4,0)
 ;;=4^F44.7
 ;;^UTILITY(U,$J,358.3,25175,2)
 ;;=^5003582
 ;;^UTILITY(U,$J,358.3,25176,0)
 ;;=F68.10^^95^1184^10
 ;;^UTILITY(U,$J,358.3,25176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25176,1,3,0)
 ;;=3^Factitious Disorder
 ;;^UTILITY(U,$J,358.3,25176,1,4,0)
 ;;=4^F68.10
 ;;^UTILITY(U,$J,358.3,25176,2)
 ;;=^5003663
 ;;^UTILITY(U,$J,358.3,25177,0)
 ;;=F54.^^95^1184^12
 ;;^UTILITY(U,$J,358.3,25177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25177,1,3,0)
 ;;=3^Psychological Factors Affecting Other Med Conditions
 ;;^UTILITY(U,$J,358.3,25177,1,4,0)
 ;;=4^F54.
 ;;^UTILITY(U,$J,358.3,25177,2)
 ;;=^5003627
 ;;^UTILITY(U,$J,358.3,25178,0)
 ;;=F44.6^^95^1184^6
 ;;^UTILITY(U,$J,358.3,25178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25178,1,3,0)
 ;;=3^Conversion Disorder w/ Special Sensory Symptom
 ;;^UTILITY(U,$J,358.3,25178,1,4,0)
 ;;=4^F44.6
 ;;^UTILITY(U,$J,358.3,25178,2)
 ;;=^5003581
 ;;^UTILITY(U,$J,358.3,25179,0)
 ;;=F44.4^^95^1184^7
 ;;^UTILITY(U,$J,358.3,25179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25179,1,3,0)
 ;;=3^Conversion Disorder w/ Speech Symptom
